• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

标准碳酸氢盐血液透析和长时缓慢碳酸氢盐血液透析中尿毒症潴留溶质的清除。

Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.

机构信息

Nephrology and Dialysis Unit, Miulli General Hospital, Acquaviva delle Fonti, Italy.

出版信息

Nephrol Dial Transplant. 2011 Apr;26(4):1296-303. doi: 10.1093/ndt/gfq543. Epub 2010 Sep 2.

DOI:10.1093/ndt/gfq543
PMID:20813765
Abstract

BACKGROUND

Several studies already stressed the importance of haemodialysis (HD) time in the removal of uraemic toxins. In those studies, however, also the amount of dialysate and/or processed blood was altered. The present study aimed to investigate the isolated effect of the factor time t (by processing the same total blood and dialysate volume in two different time schedules) on the removal and kinetic behaviour of some small, middle and protein-bound molecules.

METHODS

The present study had a crossover design: 11 stable anuric HD patients underwent two bicarbonate HD sessions (~ 4 and ~ 8 h) in a random sequence, at least 1 week apart. The GENIUS single-pass batch dialysis system and the high-flux FX80 dialysers (Fresenius Medical Care, Bad Homburg, Germany) were used. The volume of blood and dialysate processed, volume of ultrafiltration, and dialysate composition were prescribed to be the same. For each patient, blood was sampled from the arterial line at 0, 60, 120, 180 and 240 min (all sessions), and at 360 and 480 min (8-h sessions). Dialysate was sampled at the end of HD from the dialysate tank. The following solutes were investigated: (i) small molecules: urea, creatinine, phosphorus and uric acid; (ii) middle molecule: β(2)M; and (iii) protein-bound molecules: homocysteine, hippuric acid, indole-3-acetic acid and indoxyl sulphate. Total solute removals (solute concentration in the spent dialysate of each analyte × 90 L - the volume of dialysate) (TSR), clearances (TSR of a solute/area under the plasma water concentration time curve of the solute) (K), total cleared volumes (K × dialysis time) (TCV), and dialyser extraction ratios (K/blood flow rate) (ER) were determined. The percent differences of TSR, K, TCV and ER between 4- and 8-h dialyses were calculated. Single-pool Kt/Vurea, and post-dialysis percent rebounds of urea, creatinine and β(2)M were computed.

RESULTS

TSR, TCV and ER were statistically significantly larger during prolonged HD for all small and middle molecules (at least, P < 0.01). Specifically, the percent increases of TSR (8 h vs 4 h) were: for urea 22.6.0% (P < 0.003), for creatinine 24.8% (P < 0.002), for phosphorus 26.6% (P < 0.001), and for β(2)M 39.2% (P < 0.005). No statistically significant difference was observed for protein-bound solutes in any of the parameters being studied. Single-pool Kt/Vurea was 1.41 ± 0.19 for the 4-h dialysis sessions and 1.80 ± 0.29 for the 8-h ones. The difference was statistically significant (P < 0.0001). Post-dialysis percent rebounds of urea, creatinine and β(2)M were statistically significantly greater in the 4-h dialysis sessions (at least, P < 0.0002).

CONCLUSIONS

The present controlled study using a crossover design indicates that small and middle molecules are removed more adequately from the deeper compartments when performing a prolonged HD, even if blood and dialysate volumes are kept constant. Hence, factor time t is very important for these retention solutes. The kinetic behaviour of protein-bound solutes is completely different from that of small and middle molecules, mainly because of the strength of their protein binding.

摘要

背景

多项研究已经强调了血液透析(HD)时间在清除尿毒症毒素方面的重要性。然而,在这些研究中,透析液的量和/或处理的血液量也发生了改变。本研究旨在调查通过两种不同的时间表处理相同的总血液和透析液量来单独考察时间因子 t 对一些小、中分子和蛋白结合分子的清除和动力学行为的影响。

方法

本研究采用交叉设计:11 例稳定无尿 HD 患者至少间隔 1 周,以随机顺序接受两次碳酸氢盐 HD 治疗(4 小时和8 小时)。使用 GENIUS 单次通过批量透析系统和高通量 FX80 透析器(费森尤斯医疗保健,巴德洪堡,德国)。规定处理的血液和透析液量、超滤量和透析液成分相同。对于每个患者,在所有的治疗中(4 小时和 8 小时)从动脉线采集血液样本 0、60、120、180 和 240 分钟,在 8 小时治疗中还采集 360 和 480 分钟的血液样本。在 HD 结束时从透析液箱中采集透析液样本。研究了以下溶质:(i)小分子:尿素、肌酐、磷和尿酸;(ii)中分子:β(2)M;和(iii)蛋白结合分子:同型半胱氨酸、马尿酸、吲哚-3-乙酸和吲哚硫酸盐。总溶质清除率(每个分析物在消耗的透析液中的溶质浓度×90L-透析液量)(TSR)、清除率(溶质的 TSR/溶质的血浆水浓度时间曲线下面积)(K)、总清除体积(K×透析时间)(TCV)和透析器提取比(K/血流速度)(ER)。计算了 4 小时和 8 小时透析之间 TSR、K、TCV 和 ER 的百分比差异。计算了单池 Kt/Vurea 和尿素、肌酐和β(2)M 的透析后反弹百分比。

结果

所有小分子和中分子的 TSR、TCV 和 ER 在延长 HD 时均具有统计学意义上的显著增加(至少,P<0.01)。具体而言,TSR 的百分比增加(8 小时与 4 小时)为:尿素 22.6.0%(P<0.003),肌酐 24.8%(P<0.002),磷 26.6%(P<0.001),β(2)M 39.2%(P<0.005)。在所研究的参数中,没有观察到蛋白结合溶质的统计学显著差异。4 小时透析的单池 Kt/Vurea 为 1.41±0.19,8 小时透析的单池 Kt/Vurea 为 1.80±0.29。差异具有统计学意义(P<0.0001)。透析后尿素、肌酐和β(2)M 的反弹百分比在 4 小时透析治疗中统计学显著更高(至少,P<0.0002)。

结论

本研究采用交叉设计的对照研究表明,当进行延长的 HD 时,即使保持血液和透析液量不变,小分子和中分子也能更有效地从更深的隔室中清除。因此,时间因子 t 对这些保留溶质非常重要。蛋白结合溶质的动力学行为与小、中分子完全不同,主要是因为它们的蛋白结合强度。

相似文献

1
Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.标准碳酸氢盐血液透析和长时缓慢碳酸氢盐血液透析中尿毒症潴留溶质的清除。
Nephrol Dial Transplant. 2011 Apr;26(4):1296-303. doi: 10.1093/ndt/gfq543. Epub 2010 Sep 2.
2
[Depurative efficiency of intermediate and large molecules with different hemodialysis modalities].[不同血液透析方式对中大分子物质的清除效率]
Nefrologia. 2005;25 Suppl 2:15-8.
3
Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.血液透析及后稀释血液透析滤过中蛋白结合型尿毒症毒素的清除。
Nephrol Dial Transplant. 2010 Jan;25(1):212-8. doi: 10.1093/ndt/gfp437. Epub 2009 Sep 15.
4
Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis.每日血液透析期间非蛋白结合和蛋白结合尿毒症溶质的行为。
Am J Kidney Dis. 2002 Aug;40(2):339-47. doi: 10.1053/ajkd.2002.34518.
5
Removal of water-soluble and protein-bound solutes with reversed mid-dilution versus post-dilution haemodiafiltration.与后稀释相比,采用反向中稀释法进行血液透析滤过可清除水溶性和蛋白结合型溶质。
Nephrol Dial Transplant. 2012 Aug;27(8):3278-83. doi: 10.1093/ndt/gfs060. Epub 2012 Apr 5.
6
The impact of intradialytic cycling on the removal of protein-bound uraemic toxins: A randomised cross-over study.透析中循环对蛋白结合尿毒症毒素清除的影响:一项随机交叉研究。
Int J Artif Organs. 2021 Mar;44(3):156-164. doi: 10.1177/0391398820949880. Epub 2020 Aug 21.
7
Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes.超高通量三醋酸纤维素透析器膜对非蛋白结合和蛋白结合尿毒症溶质的清除作用。
Nephrol Dial Transplant. 2007 Jul;22(7):2006-12. doi: 10.1093/ndt/gfm065. Epub 2007 Apr 27.
8
Haemodynamic stability in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.标准碳酸氢盐血液透析和长时间低流量碳酸氢盐血液透析中的血液动力学稳定性。
Nephrol Dial Transplant. 2011 Jan;26(1):252-8. doi: 10.1093/ndt/gfq351. Epub 2010 Jun 22.
9
The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients.高透析液碳酸氢盐浓度对慢性血液透析患者的降钾作用更快。
Nephrol Dial Transplant. 2005 Mar;20(3):591-7. doi: 10.1093/ndt/gfh661. Epub 2005 Feb 1.
10
Phosphate mass removal during hemodialysis: a comparison between eKT/V-matched conventional and extended dialysis.血液透析过程中磷酸盐质量的清除:eKT/V 匹配的常规透析与延长透析的比较。
Am J Nephrol. 2012;36(2):121-6. doi: 10.1159/000338675. Epub 2012 Jul 7.

引用本文的文献

1
Extended-Hours Hemodialysis Without Dietary Restrictions Reduces Risk of Vascular Calcification.无饮食限制的延长时间血液透析可降低血管钙化风险。
J Med Cases. 2025 Aug 22;16(8):300-308. doi: 10.14740/jmc5146. eCollection 2025 Aug.
2
Comparative efficacy of expanded hemodialysis and online hemodiafiltration: a systematic review and meta-analysis.延长血液透析与联机血液透析滤过的比较疗效:一项系统评价和荟萃分析。
Int Urol Nephrol. 2025 May 10. doi: 10.1007/s11255-025-04559-2.
3
Impact of convective clearance on intra-dialytic potassium removal in chronic dialysis patients.
对流清除对慢性透析患者透析期间钾清除的影响。
Artif Organs. 2025 Feb;49(2):300-309. doi: 10.1111/aor.14883. Epub 2024 Oct 8.
4
Effect of Membrane Permeance and System Parameters on the Removal of Protein-Bound Uremic Toxins in Hemodialysis.膜通透性和系统参数对血液透析清除蛋白结合尿毒症毒素的影响。
Ann Biomed Eng. 2024 Mar;52(3):526-541. doi: 10.1007/s10439-023-03397-6. Epub 2023 Nov 22.
5
Medium cut-off dialyzer for middle molecular uremic toxins in AKI and chronic dialysis.中分子尿毒症毒素的中截留量透析器在急性肾损伤和慢性透析中的应用。
J Nephrol. 2024 Jan;37(1):23-37. doi: 10.1007/s40620-023-01771-0. Epub 2023 Oct 16.
6
Derivation and elimination of uremic toxins from kidney-gut axis.肾-肠轴中尿毒症毒素的产生与清除
Front Physiol. 2023 Aug 15;14:1123182. doi: 10.3389/fphys.2023.1123182. eCollection 2023.
7
Gut-Derived Uremic Toxins in CKD: An Improved Approach for the Evaluation of Serum Indoxyl Sulfate in Clinical Practice.慢性肾脏病中肠道来源的尿毒症毒素:一种改进的血清吲哚硫酸酯在临床实践中的评估方法。
Int J Mol Sci. 2023 Mar 7;24(6):5142. doi: 10.3390/ijms24065142.
8
Fecal Microbiota Transplantation in Reducing Uremic Toxins Accumulation in Kidney Disease: Current Understanding and Future Perspectives.粪便微生物移植在减少肾脏病中尿毒症毒素积累方面的作用:当前的认识和未来展望。
Toxins (Basel). 2023 Jan 31;15(2):115. doi: 10.3390/toxins15020115.
9
Improved Dialysis Removal of Protein-Bound Uraemic Toxins with a Combined Displacement and Adsorption Technique.联合置换与吸附技术提高蛋白结合型尿毒症毒素的透析清除率。
Blood Purif. 2022;51(6):548-558. doi: 10.1159/000518065. Epub 2021 Aug 16.
10
Serum total indoxyl sulfate and clinical outcomes in hemodialysis patients: results from the Japan Dialysis Outcomes and Practice Patterns Study.血液透析患者的血清总硫酸吲哚酚与临床结局:日本透析结局与实践模式研究结果
Clin Kidney J. 2020 Jul 31;14(4):1236-1243. doi: 10.1093/ckj/sfaa121. eCollection 2021 Apr.